Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now?

Is CAI a good stock to buy? We came across a bullish thesis on Caris Life Sciences, Inc. on InfoArb Sheets’s Substack. In this article, we will summarize the bulls’ thesis on CAI. Caris Life Sciences, Inc.'s share was trading at $18.47 as of June 18^th. CAI’s forward P/E was 46.95 according to Yahoo Finance.

[caption id="attachment_575381" align="aligncenter" width="750"] Likoper/Shutterstock.com[/caption]

Caris Life Sciences is a precision oncology and AI-enabled molecular diagnostics company focused on cancer profiling, therapy selection, early cancer detection,...